Active ingredients: etoposide
What it is used for
1 - small cell carcinoma of the lung 2 - acute monocytic and myelomonocytic leukaemia 3 - Hodgkins disease 4 - Non-Hodgkins lymphonia INDICATIONS AS AT 5 OCTOBER 2000: In the treatment of: 1. Small cell carcinoma of the lung. 2. Acute monocytic and myelomonocytic leukaemia. 3. Hodgkin's disease. 4. Non-Hodgkin's lymphoma.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Opaque, pink, oval, soft gelatin capsules, diameter 8.1mm, length 19.8mm
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient etoposide
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems